Cargando…

Preliminary Efficacy of a Cognitive Behavioral Therapy Text Messaging Intervention Targeting Alcohol Use and Antiretroviral Therapy Adherence: A Randomized Clinical Trial

To date, no studies have reported the use of text messaging to deliver cognitive behavioral therapy (CBT) to alcohol users with HIV. We developed and evaluated a text messaging-based program to deliver CBT targeting both alcohol use and adherence to antiretroviral (ART) medications for adults with a...

Descripción completa

Detalles Bibliográficos
Autores principales: Glasner, Suzette, Chokron Garneau, Helene, Ang, Alfonso, Ray, Lara, Venegas, Alexandra, Rawson, Richard, Kalichman, Seth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067560/
https://www.ncbi.nlm.nih.gov/pubmed/32163431
http://dx.doi.org/10.1371/journal.pone.0229557
_version_ 1783505419749031936
author Glasner, Suzette
Chokron Garneau, Helene
Ang, Alfonso
Ray, Lara
Venegas, Alexandra
Rawson, Richard
Kalichman, Seth
author_facet Glasner, Suzette
Chokron Garneau, Helene
Ang, Alfonso
Ray, Lara
Venegas, Alexandra
Rawson, Richard
Kalichman, Seth
author_sort Glasner, Suzette
collection PubMed
description To date, no studies have reported the use of text messaging to deliver cognitive behavioral therapy (CBT) to alcohol users with HIV. We developed and evaluated a text messaging-based program to deliver CBT targeting both alcohol use and adherence to antiretroviral (ART) medications for adults with alcohol use disorders and comorbid HIV. Participants were randomly assigned to receive either a 12-week CBT-based text messaging intervention (ALC-TXT-CBT) targeting ART adherence and alcohol use (n = 18); or an informational pamphlet (INFO) comprising educational content focused on alcohol use and medication adherence (n = 17). ART adherence and alcohol use were compared for those in ALC-TXT-CBT to INFO across baseline and 12-week (i.e., treatment-end) assessments using mixed model regression analyses and paired t-tests. Relative to those in INFO, ALC-TXT-CBT participants evidenced increases in ART adherence, measured by phone-based unannounced pill counts (β = .16, p = .04), and biochemically by viral load (t = -2.0, p = .04) at treatment-end. ALC-TXT-CBT participation was also associated with reductions in heavy drinking at treatment-end (t = 2.7, p = 0.02), while overall alcohol use frequency did not differ significantly between groups (t = 1.5, p = 0.07). Findings demonstrated promising preliminary evidence for the efficacy of ALC-TXT-CBT in improving medication adherence and reducing heavy alcohol use among individuals with alcohol use disorders and comorbid HIV infection. TRIAL REGISTRATION: This trial was registered with ClinicalTrials.gov, NCT02603471.
format Online
Article
Text
id pubmed-7067560
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-70675602020-03-23 Preliminary Efficacy of a Cognitive Behavioral Therapy Text Messaging Intervention Targeting Alcohol Use and Antiretroviral Therapy Adherence: A Randomized Clinical Trial Glasner, Suzette Chokron Garneau, Helene Ang, Alfonso Ray, Lara Venegas, Alexandra Rawson, Richard Kalichman, Seth PLoS One Research Article To date, no studies have reported the use of text messaging to deliver cognitive behavioral therapy (CBT) to alcohol users with HIV. We developed and evaluated a text messaging-based program to deliver CBT targeting both alcohol use and adherence to antiretroviral (ART) medications for adults with alcohol use disorders and comorbid HIV. Participants were randomly assigned to receive either a 12-week CBT-based text messaging intervention (ALC-TXT-CBT) targeting ART adherence and alcohol use (n = 18); or an informational pamphlet (INFO) comprising educational content focused on alcohol use and medication adherence (n = 17). ART adherence and alcohol use were compared for those in ALC-TXT-CBT to INFO across baseline and 12-week (i.e., treatment-end) assessments using mixed model regression analyses and paired t-tests. Relative to those in INFO, ALC-TXT-CBT participants evidenced increases in ART adherence, measured by phone-based unannounced pill counts (β = .16, p = .04), and biochemically by viral load (t = -2.0, p = .04) at treatment-end. ALC-TXT-CBT participation was also associated with reductions in heavy drinking at treatment-end (t = 2.7, p = 0.02), while overall alcohol use frequency did not differ significantly between groups (t = 1.5, p = 0.07). Findings demonstrated promising preliminary evidence for the efficacy of ALC-TXT-CBT in improving medication adherence and reducing heavy alcohol use among individuals with alcohol use disorders and comorbid HIV infection. TRIAL REGISTRATION: This trial was registered with ClinicalTrials.gov, NCT02603471. Public Library of Science 2020-03-12 /pmc/articles/PMC7067560/ /pubmed/32163431 http://dx.doi.org/10.1371/journal.pone.0229557 Text en © 2020 Glasner et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Glasner, Suzette
Chokron Garneau, Helene
Ang, Alfonso
Ray, Lara
Venegas, Alexandra
Rawson, Richard
Kalichman, Seth
Preliminary Efficacy of a Cognitive Behavioral Therapy Text Messaging Intervention Targeting Alcohol Use and Antiretroviral Therapy Adherence: A Randomized Clinical Trial
title Preliminary Efficacy of a Cognitive Behavioral Therapy Text Messaging Intervention Targeting Alcohol Use and Antiretroviral Therapy Adherence: A Randomized Clinical Trial
title_full Preliminary Efficacy of a Cognitive Behavioral Therapy Text Messaging Intervention Targeting Alcohol Use and Antiretroviral Therapy Adherence: A Randomized Clinical Trial
title_fullStr Preliminary Efficacy of a Cognitive Behavioral Therapy Text Messaging Intervention Targeting Alcohol Use and Antiretroviral Therapy Adherence: A Randomized Clinical Trial
title_full_unstemmed Preliminary Efficacy of a Cognitive Behavioral Therapy Text Messaging Intervention Targeting Alcohol Use and Antiretroviral Therapy Adherence: A Randomized Clinical Trial
title_short Preliminary Efficacy of a Cognitive Behavioral Therapy Text Messaging Intervention Targeting Alcohol Use and Antiretroviral Therapy Adherence: A Randomized Clinical Trial
title_sort preliminary efficacy of a cognitive behavioral therapy text messaging intervention targeting alcohol use and antiretroviral therapy adherence: a randomized clinical trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067560/
https://www.ncbi.nlm.nih.gov/pubmed/32163431
http://dx.doi.org/10.1371/journal.pone.0229557
work_keys_str_mv AT glasnersuzette preliminaryefficacyofacognitivebehavioraltherapytextmessaginginterventiontargetingalcoholuseandantiretroviraltherapyadherencearandomizedclinicaltrial
AT chokrongarneauhelene preliminaryefficacyofacognitivebehavioraltherapytextmessaginginterventiontargetingalcoholuseandantiretroviraltherapyadherencearandomizedclinicaltrial
AT angalfonso preliminaryefficacyofacognitivebehavioraltherapytextmessaginginterventiontargetingalcoholuseandantiretroviraltherapyadherencearandomizedclinicaltrial
AT raylara preliminaryefficacyofacognitivebehavioraltherapytextmessaginginterventiontargetingalcoholuseandantiretroviraltherapyadherencearandomizedclinicaltrial
AT venegasalexandra preliminaryefficacyofacognitivebehavioraltherapytextmessaginginterventiontargetingalcoholuseandantiretroviraltherapyadherencearandomizedclinicaltrial
AT rawsonrichard preliminaryefficacyofacognitivebehavioraltherapytextmessaginginterventiontargetingalcoholuseandantiretroviraltherapyadherencearandomizedclinicaltrial
AT kalichmanseth preliminaryefficacyofacognitivebehavioraltherapytextmessaginginterventiontargetingalcoholuseandantiretroviraltherapyadherencearandomizedclinicaltrial